Chemoinformaics analysis of 2-Methylbutyl hexanoate
| Molecular Weight | 186.295 | nRot | 7 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 1 |
| Exact Molecular Weight | 186.162 | nRing | 0 |
| Solubility: LogS | -3.749 | nHRing | 0 |
| Solubility: LogP | 4.089 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.6434 |
| nHD | 0 | BPOL | 24.6746 |
| QED | 0.451 |
| Synth | 2.342 |
| Natural Product Likeliness | 0.595 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.148 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.38 |
| MDCK | 0.0000218 |
| BBB | 0.871 |
| PPB | 0.905874 |
| VDSS | 0.565 |
| FU | 0.0903457 |
| CYP1A2-inh | 0.953 |
| CYP1A2-sub | 0.529 |
| CYP2c19-inh | 0.535 |
| CYP2c19-sub | 0.572 |
| CYP2c9-inh | 0.523 |
| CYP2c9-sub | 0.447 |
| CYP2d6-inh | 0.061 |
| CYP2d6-sub | 0.102 |
| CYP3a4-inh | 0.146 |
| CYP3a4-sub | 0.208 |
| CL | 11.11 |
| T12 | 0.777 |
| hERG | 0.039 |
| Ames | 0.009 |
| ROA | 0.061 |
| SkinSen | 0.919 |
| Carcinogencity | 0.255 |
| EI | 0.966 |
| Respiratory | 0.486 |
| NR-Aromatase | 0.009 |
| Antiviral | No |
| Prediction | 0.683841 |